20
Ipca Laboratories Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Hydrochlorothiazide, Process III, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2012-044 - Rev 02
This Chemical Type CEP, issued on September 26, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 394 associated with this CEP further emphasizes